ARTICLE
7 February 2020

Understanding The Inventive Step For Pharma And Bio-Pharma Inventions In India

L
LexOrbis

Contributor

LexOrbis is a premier full-service IP law firm with 270 personnel including 130+ attorneys at its three offices in India namely, New Delhi, Bangalore and Mumbai. The firm provides business oriented and cost-effective solutions for protection, enforcement, transaction, and commercialization of all forms of intellectual property in India and globally. The Firm has been consistently ranked amongst the Top- 5 IP firms in India for over the past one decade and is well-known for managing global patent, designs and trademark portfolios of many technology companies and brand owners.
The Indian pharmaceutical and biopharmaceutical industry has an important position in providing medical and alternative therapies worldwide.
India Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

The Indian pharmaceutical and biopharmaceutical industry has an important position in providing medical and alternative therapies worldwide. Both sectors have the potential to provide the most advanced and cost-effective supplies globally and to work in parallel to provide an optimum solution. Additionally, ongoing research in the pharma/bio-pharma sector for combating diseases is vital for public health and, subsequently, patent protection is equally important for the researchers.

Read the article (pdf) >>

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More